MX2009006818A - Procesos para la preparacion de (3r,4r)-n-(4-clorofenil)-1-(2,2-di fluoroetil)-n'-[2-fluoro-4-(2-oxo-1(2h)piridinil)fenil]-3,4-pirro dinadicarboxamida. - Google Patents
Procesos para la preparacion de (3r,4r)-n-(4-clorofenil)-1-(2,2-di fluoroetil)-n'-[2-fluoro-4-(2-oxo-1(2h)piridinil)fenil]-3,4-pirro dinadicarboxamida.Info
- Publication number
- MX2009006818A MX2009006818A MX2009006818A MX2009006818A MX2009006818A MX 2009006818 A MX2009006818 A MX 2009006818A MX 2009006818 A MX2009006818 A MX 2009006818A MX 2009006818 A MX2009006818 A MX 2009006818A MX 2009006818 A MX2009006818 A MX 2009006818A
- Authority
- MX
- Mexico
- Prior art keywords
- processes
- pyrrolidinedicarboxamide
- difluoroethyl
- pyridinyl
- chlorophenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
La invención se refiere a los procesos para la manufactura de un derivado de pirrolidina-3,4-dicarboxamida de la fórmula (I), y los intermediarios útiles para esos procesos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06126969 | 2006-12-22 | ||
PCT/EP2007/063833 WO2008077797A1 (en) | 2006-12-22 | 2007-12-12 | Processes for the preparation of (3r, 4r) -n- (4 -chlorophenyl) -1- (2, 2-difluoroethyl) -n' - [2-fluoro-4- (2-oxo-1 (2h) -pyridinyl) phenyl] -3, 4-pyrrolidinedicarboxamide |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009006818A true MX2009006818A (es) | 2009-07-02 |
Family
ID=39054096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009006818A MX2009006818A (es) | 2006-12-22 | 2007-12-12 | Procesos para la preparacion de (3r,4r)-n-(4-clorofenil)-1-(2,2-di fluoroetil)-n'-[2-fluoro-4-(2-oxo-1(2h)piridinil)fenil]-3,4-pirro dinadicarboxamida. |
Country Status (10)
Country | Link |
---|---|
US (1) | US7872141B2 (es) |
EP (1) | EP2097401A1 (es) |
JP (1) | JP2010513381A (es) |
KR (1) | KR20090094386A (es) |
CN (1) | CN101611026A (es) |
AU (1) | AU2007338102A1 (es) |
BR (1) | BRPI0720849A2 (es) |
CA (1) | CA2672835A1 (es) |
MX (1) | MX2009006818A (es) |
WO (1) | WO2008077797A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009510478A (ja) * | 2005-10-03 | 2009-03-12 | バイオサイト インコーポレイテッド | 全身性炎症反応症候群の診断および/または予後診断のための方法および組成物 |
JP2010526789A (ja) * | 2007-05-10 | 2010-08-05 | エフ.ホフマン−ラ ロシュ アーゲー | Fxaインヒビターの新規固形形態 |
CN102241618B (zh) * | 2010-05-14 | 2013-08-07 | 北京大学 | 1,3,4-三取代或3,4-二取代的吡咯环化合物的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050013627A (ko) * | 2002-06-25 | 2005-02-04 | 와이어쓰 | Pr 조절제로서의 사이클로티오카바메이트 유도체 및피부 질환을 치료하기 위한 이의 용도 |
US7192956B2 (en) * | 2002-06-25 | 2007-03-20 | Wyeth | Methods of treating hormone-related conditions using cyclothiocarbamate derivatives |
JP2007502257A (ja) * | 2003-08-14 | 2007-02-08 | エフ.ホフマン−ラ ロシュ アーゲー | γアミノ酪酸作動性モジュレーター |
US7550487B2 (en) | 2004-03-26 | 2009-06-23 | Hoffmann-La Roche Inc. | Pyrrolidine-3,4-dicarboxamide derivatives |
JP2008540370A (ja) * | 2005-05-04 | 2008-11-20 | エフ.ホフマン−ラ ロシュ アーゲー | ヘテロ環式抗ウイルス化合物 |
-
2007
- 2007-12-12 CN CNA2007800515025A patent/CN101611026A/zh active Pending
- 2007-12-12 BR BRPI0720849-9A2A patent/BRPI0720849A2/pt not_active IP Right Cessation
- 2007-12-12 CA CA002672835A patent/CA2672835A1/en not_active Abandoned
- 2007-12-12 MX MX2009006818A patent/MX2009006818A/es not_active Application Discontinuation
- 2007-12-12 WO PCT/EP2007/063833 patent/WO2008077797A1/en active Application Filing
- 2007-12-12 EP EP07857495A patent/EP2097401A1/en not_active Withdrawn
- 2007-12-12 KR KR1020097015312A patent/KR20090094386A/ko active IP Right Grant
- 2007-12-12 AU AU2007338102A patent/AU2007338102A1/en not_active Abandoned
- 2007-12-12 JP JP2009541998A patent/JP2010513381A/ja active Pending
- 2007-12-19 US US11/959,486 patent/US7872141B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2010513381A (ja) | 2010-04-30 |
BRPI0720849A2 (pt) | 2014-03-11 |
CN101611026A (zh) | 2009-12-23 |
CA2672835A1 (en) | 2008-07-03 |
KR20090094386A (ko) | 2009-09-04 |
WO2008077797A1 (en) | 2008-07-03 |
EP2097401A1 (en) | 2009-09-09 |
AU2007338102A1 (en) | 2008-07-03 |
US7872141B2 (en) | 2011-01-18 |
US20080214826A1 (en) | 2008-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007105058A3 (en) | Pyrazole compounds | |
HK1110588A1 (en) | Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase | |
SG170729A1 (en) | Processes and intermediates for preparing steric compounds | |
TW200716107A (en) | Polymorphs of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester | |
MY143249A (en) | 4-substituted pyrrolidin-2-ones and their use | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
TW200745039A (en) | Isotopically substituted pantoprazole | |
CL2007002949A1 (es) | Forma cristalina del compuesto 2-cloro-5-(3,6-dihidro-3-metil-2,6-dioxo-4-(trifluorometil)-1-(2h)-pirimidinil)-4-fluoro-n-((metil(1-metiletil)amino)sulfonil)benzamida; proceso para la preparacion de dicha forma cristalina; composicion fitoprotectora; | |
WO2007023111A3 (en) | P38 map kinase inhibitors and methods for using the same | |
WO2007117778A3 (en) | Quinolones useful as inducible nitric oxide synthase inhibitors | |
MX2010002938A (es) | Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer. | |
HK1159614A1 (en) | Caspase inhibitors and uses thereof | |
MX2009006907A (es) | Activador de glucocinasa. | |
MY156965A (en) | Plant disease control composition and its use | |
TNSN06260A1 (en) | Process for the preparation of tryptase inhibitors | |
MX2008001778A (es) | Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma. | |
MX2009006818A (es) | Procesos para la preparacion de (3r,4r)-n-(4-clorofenil)-1-(2,2-di fluoroetil)-n'-[2-fluoro-4-(2-oxo-1(2h)piridinil)fenil]-3,4-pirro dinadicarboxamida. | |
WO2006079720A8 (fr) | Nouveaux derives d1oximes heterocycliques, leur procede de preparation et leur utilisation comme agents hypoglycemiants et hypoli pemiants | |
HK1107984A1 (en) | Pyrrolopyridine-2-carboxylic acid amide derivativeuseful as inhibitor of glycogen phosphorylase | |
IL189286A0 (en) | Novel cysteine protease inhibitors and their therapeutic applications | |
EA200801139A1 (ru) | Композиция для аэрозольной ингаляции | |
TW200714596A (en) | Isotopically substituted proton pump inhibitors | |
WO2006076350A3 (en) | Processes for the preparation of aminoethoxybenzyl alcohols | |
MY156678A (en) | Pest controlling composition and method of controlling pest | |
TW200612944A (en) | 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-(substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |